Literature DB >> 10610720

The mouse SHIP2 (Inppl1) gene: complementary DNA, genomic structure, promoter analysis, and gene expression in the embryo and adult mouse.

S Schurmans1, R Carrió, J Behrends, V Pouillon, J Merino, S Clément.   

Abstract

SHIP2 is a new member of the inositol polyphosphate 5-phosphatase family showing homology to SHIP1. The structure of both enzymes is characterized by the presence of a 5' SH2 domain, a central catalytic domain, and a 3' proline-rich region. Recent results suggest that SHIP2 and SHIP1 act downstream of various receptors by removing a phosphate from the 5' position of the phosphatidylinositol 3'-kinase phosphatidylinositol 3,4, 5-triphosphate product and of inositol 1,3,4,5-tetrakisphosphate. Human SHIP2 is highly expressed in adult heart, skeletal muscle, and placenta, whereas SHIP1 expression is limited to the hematopoietic system. We report here the molecular analysis of the mouse SHIP2 cDNA and the corresponding protein, the structure of the gene, and the identification of its promoter. SHIP2 mRNA expression was analyzed in embryonic and adult mouse tissues by reverse transcription-polymerase chain reaction and in situ hybridization. In embryonic day 15.5 mice, SHIP2 was strongly expressed in the liver, specific regions of the central nervous system, the thymus, the lung, and the cartilage perichondrium. In adult mice, SHIP2 mRNA was markedly present in the brain and the thymus and at different stages of spermatozoa maturation in the seminiferous tubules. The subtle differences in the protein structure of SHIP2 and SHIP1 as well as their different patterns of expression are discussed. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610720     DOI: 10.1006/geno.1999.5995

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

Review 1.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

2.  SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading.

Authors:  N Prasad; R S Topping; S J Decker
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

3.  The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus.

Authors:  Shannon McNulty; Kimberly Powell; Christophe Erneux; Daniel Kalman
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

4.  Brief calorie restriction increases Akt2 phosphorylation in insulin-stimulated rat skeletal muscle.

Authors:  Carrie E McCurdy; Robert T Davidson; Gregory D Cartee
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-10       Impact factor: 4.310

5.  The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.

Authors:  Yoshiyuki Soeda; Hiroshi Tsuneki; Hayato Muranaka; Norihiko Mori; Shuji Hosoh; Yoshinori Ichihara; Syota Kagawa; Xu Wang; Naoki Toyooka; Yusaku Takamura; Teruko Uwano; Hisao Nishijo; Tsutomu Wada; Toshiyasu Sasaoka
Journal:  Mol Endocrinol       Date:  2010-09-09

6.  MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.

Authors:  Jia Yu; David G Ryan; Spiro Getsios; Michelle Oliveira-Fernandes; Anees Fatima; Robert M Lavker
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

7.  Phosphatases: the new brakes for cancer development?

Authors:  Qingxiu Zhang; Francois X Claret
Journal:  Enzyme Res       Date:  2011-10-31

Review 8.  SHIPping out diabetes-Metformin, an old friend among new SHIP2 inhibitors.

Authors:  Sanna Lehtonen
Journal:  Acta Physiol (Oxf)       Date:  2019-08-12       Impact factor: 6.311

9.  Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells.

Authors:  Yumiko Fujii; Naoko Murata-Kamiya; Masanori Hatakeyama
Journal:  Cancer Sci       Date:  2020-04-13       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.